Rescale Partners with Google Cloud and Microsoft Azure to Accelerate the Race for COVID-19 Vaccine with Cloud Supercomputers for Researchers

Rescale Inc., in partnership with Google Cloud and Microsoft Azure, has launched a program to provide free high-performance computing (HPC) resources to researchers working on COVID-19 vaccines and test kits. This initiative allows scientists to access powerful cloud-based HPC capabilities without the need for setup or IT teams, enabling faster simulation and collaboration across the globe. The program aims to expedite vaccine discovery and development by leveraging Rescale's platform, which integrates seamlessly with cloud resources from Google and Microsoft. Key figures from these companies emphasize the importance of speeding up research and eliminating barriers to access. Bionano Genomics is utilizing Rescale's platform to accelerate genome studies that could help identify genetic variations related to COVID-19 susceptibility. The availability of cloud HPC is set to revolutionize the way startups and enterprises develop new drugs by removing the necessity of on-premises supercomputers, thus allowing for scalable and customized processing. Rescale and its partners are committed to facilitating rapid scientific breakthroughs to combat the pandemic.